We are grateful to CureSearch for Children's Cancer for the $40,000 grant to pursue our proposal, COG-STS Preclinical Targeted
Agent Trial Design Support. Through this project we will provide the Children's Oncology Group Soft Tissue Sarcoma committee with real-time testing of a targeted therapeutic for rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcomas.
No comments:
Post a Comment